BIOXYNE LIMITED - Announcements

0.96%

5.2¢

Market Cap $111.8M

Healthcare Biotechnology Cannabis

Bioxyne Limited is an Australia-based international consumer health and pharmaceutical... Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Announcements

Filter Results

All Price Sensitive Only

BXN	Quarterly Activities Report and Appendix 4C-BXN.AX	PRICE SENSITIVE	26/10/16	223.13KB	Share
BXN	Notice of Annual General Meeting/Proxy Form-BXN.AX		24/10/16	915.76KB	Share
BXN	Recruitment for Clinical Trial of Proprietary Probiotic PCC-BXN.AX		17/10/16	135.19KB	Share
BXN	Annual Report to shareholders-BXN.AX		29/09/16	825.15KB	Share
BXN	Appendix 4G and Corporate Governance Statement-BXN.AX		29/09/16	236.02KB	Share
BXN	Becoming a substantial holder-BXN.AX		12/09/16	146.52KB	Share
BXN	Ceasing to be a substantial holder-BXN.AX		09/09/16	926.49KB	Share
BXN	Management Restructure-BXN.AX		01/09/16	140.75KB	Share
BXN	Company Secretary Appointment/Details of Company Address-BXN.AX		01/09/16	131.99KB	Share
BXN	Appendix 4E - Preliminary Final Report-BXN.AX	PRICE SENSITIVE	30/08/16	676.8KB	Share
BXN	Appendix 4C - June Quarterly-BXN.AX	PRICE SENSITIVE	28/07/16	578.81KB	Share
BXN	Bioxyne Commences New Clinical Trial-BXN.AX	PRICE SENSITIVE	23/06/16		Share
BXN	Bioxyne Commences New Clinical Trial-BXN.AX	PRICE SENSITIVE	23/06/16	323.48KB	Share
BXN	Directors Equity Based Incentives-BXN.AX		15/06/16	398.12KB	Share
BXN	Board Exercises Options-BXN.AX		05/05/16	238.83KB	Share
BXN	Appendix 3B - Exercise of Directors' Options-BXN.AX		05/05/16	529.67KB	Share
BXN	Change of Director's Interest Notice - Patrick Ford-BXN.AX		05/05/16	227.31KB	Share
BXN	Change of Director's Interest Notice - Anthony Ho-BXN.AX		05/05/16	225.46KB	Share
BXN	Change of Director's Interest Notice - George Cameron-Dow-BXN.AX		05/05/16	227.82KB	Share
BXN	Appendix 4C - March quarterly-BXN.AX	PRICE SENSITIVE	26/04/16	578.96KB	Share
BXN	Bioxyne Announces 2016 Goals		31/03/16	335.38KB	Share
BXN	Bioxyne Investor Presentation		29/03/16	2.12MB	Share
BXN	Change of Director's Interest Notice - A Ho		16/03/16	225.28KB	Share
BXN	Appendix 4D - Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/16	1.4MB	Share
BXN	Initial Director's Interest Notice - Dr Peter French		15/02/16	290.07KB	Share
BXN	Appointment of Executive Director Dr Peter French		15/02/16	330.67KB	Share
BXN	Tony Ho - Change of Director's Interest Notice		04/02/16	303.66KB	Share
BXN	Appendix 4C - December Quarterly	PRICE SENSITIVE	21/01/16	387.19KB	Share
BXN	Results of Annual General Meeting		20/11/15	259.72KB	Share
BXN	Mariposa Health Inc. Investment Update	PRICE SENSITIVE	11/11/15	330.15KB	Share
BXN	Change of Director's Interest Notice - Patrick Ford		02/11/15	470.63KB	Share
BXN	Appendix 4C - September Quarterly	PRICE SENSITIVE	29/10/15	486.61KB	Share
BXN	2015 Notice of Annual General Meeting and Proxy Form		20/10/15	734.56KB	Share
BXN	Appendix 4G		01/10/15	212.86KB	Share
BXN	2015 Annual Report to Shareholders		30/09/15	1.59MB	Share
BXN	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	31/08/15	701.11KB	Share
BXN	2015 Financial Year Profit Update	PRICE SENSITIVE	17/08/15	222.27KB	Share
BXN	Appendix 4C - June Quarterly	PRICE SENSITIVE	30/07/15	619.87KB	Share
BXN	Becoming a Substantial Holder - Ondek Pty Ltd		20/05/15	1.01MB	Share
BXN	Change of Director's Interest Notice - George Cameron-Dow		20/05/15	265.67KB	Share
BXN	Ceasing to be a substantial holder - Fleming		20/05/15	72.57KB	Share
BXN	Appendix 4C - March Quarterly	PRICE SENSITIVE	28/04/15	551.29KB	Share
BXN	Change of Director's Interest Notice - George Cameron-Dow		16/04/15	265.62KB	Share
BXN	Appendix 4D - Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/15	1.56MB	Share
BXN	Change of Director's Interest Notice - P Ford		10/02/15	480.18KB	Share
BXN	Change of Director's Interest Notice - A Ho		30/01/15	262.07KB	Share
BXN	Appendix 4C - December Quarterly	PRICE SENSITIVE	28/01/15	681.79KB	Share
BXN	Change of Director's Interest Notice - A Ho		11/12/14	262.83KB	Share
BXN	Change of Director's Interest Notice - P Ford		11/12/14	453.3KB	Share
BXN	Change of Director's Interest Notice - G Cameron-Dow		11/12/14	458.84KB	Share
BXN	Appendix 3B - Issue of Employee Options		11/12/14	978.87KB	Share
BXN	Change of Registered Office		28/11/14	238.07KB	Share
BXN	Results of 2014 Annual General Meeting		28/11/14	305.74KB	Share
BXN	Change of Director's Interest Notice - P Ford		24/11/14	452.8KB	Share
BXN	Change of Director's Interest Notice - A Ho		21/11/14	451.1KB	Share
BXN	Notice of 2014 Annual General Meeting/Proxy Form		29/10/14	1.5MB	Share
BXN	Appendix 4C - September Quarterly	PRICE SENSITIVE	27/10/14	667.26KB	Share
BXN	Annual Report to Shareholders		30/09/14	1.61MB	Share
BXN	Appointment of Strategic Marketing Consultant		18/09/14	355.39KB	Share
BXN	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	29/08/14	895.86KB	Share
BXN	Top 20 securityholders		19/08/14	360.84KB	Share
BXN	Appendix 4C - June Quarterly	PRICE SENSITIVE	28/07/14	666.03KB	Share
BXN	Initial Director's Interest Notice - George Cameron-Dow		21/07/14	374.54KB	Share
BXN	Final Director's Interest Notice - Jeremy Curnock-Cook		21/07/14	336.03KB	Share
BXN	Resignation and Appointment of Directors		21/07/14	309.78KB	Share
BXN	Change of Director's Interest Notice - Jeremy Curnock-Cook		21/07/14	714.87KB	Share
BXN	Ceasing to be substantial holder - Phillip Asset Management		21/07/14	25.35KB	Share
BXN	Becoming a substantial holder - Fleming SG Capital SO		21/07/14	126.61KB	Share
BXN	Options Expiry		16/05/14	300.54KB	Share
BXN	Appendix 4C - March Quarterly	PRICE SENSITIVE	30/04/14	686.08KB	Share
BXN	Appendix 3B - Quotation Following ASX Escrow Release		04/04/14	1.39MB	Share
BXN	Change of Director's Interest Notice - P Ford		01/04/14	410.13KB	Share
BXN	Release of Shares from Escrow		18/03/14	311.47KB	Share
BXN	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/14	1.97MB	Share
BXN	Change of Director's Interest Notice - P Ford		25/02/14	719.66KB	Share
BXN	Completion of the Sale of HI-164 Program		25/02/14	256.2KB	Share
BXN	Change of Director's Interest Notice - P Ford		19/02/14	720.44KB	Share
BXN	Change in substantial holding		14/02/14	512.17KB	Share
BXN	Appendix 4C - December Quarterly	PRICE SENSITIVE	31/01/14	672.9KB	Share
BXN	Amended Change of Director's Interest Notices		31/01/14	1.33MB	Share
BXN	Change of Director's Interest Notice - P Ford		30/01/14	48.4KB	Share
BXN	Change of Director's Interest Notice - J C Cook		30/01/14	46.95KB	Share
BXN	Change of Director's Interest Notice - A P Ho		30/01/14	48.02KB	Share
BXN	Appendix 3B - EGM Approved Share and Option Issues		27/12/13	1.01MB	Share
BXN	Results of EGM		23/12/13	435.71KB	Share
BXN	Expiry of Unquoted Options		04/12/13	301.97KB	Share
BXN	Bioxyne Limited CEO Steps Down	PRICE SENSITIVE	02/12/13	181.25KB	Share
BXN	Sale of HI-164OV Hunter Immunology Pty Ltd	PRICE SENSITIVE	02/12/13	233.45KB	Share
BXN	Results of 2013 AGM		29/11/13	418.92KB	Share
BXN	Notice of Extraordinary General Meeting/Proxy Form		22/11/13	639.37KB	Share
BXN	Response to ASX query	PRICE SENSITIVE	06/11/13	381.53KB	Share
BXN	Appendix 4C - September Quarterly	PRICE SENSITIVE	31/10/13	664.58KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		31/10/13	546.76KB	Share
BXN	30 June 2013 Full Year Statutory Accounts		23/09/13	1.78MB	Share
BXN	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	30/08/13	1.1MB	Share
BXN	Response to ASX query	PRICE SENSITIVE	06/08/13	378.6KB	Share
BXN	Appendix 4C - June Quarterly	PRICE SENSITIVE	31/07/13	650.81KB	Share
BXN	Company Secretary Resignation		06/06/13	315.29KB	Share
BXN	Termination of proposed acquisition - Vitality Devices	PRICE SENSITIVE	23/05/13	216.52KB	Share
BXN	Appendix 4C - quarterly - 31 March 2013	PRICE SENSITIVE	30/04/13	650.95KB	Share

BXN Quarterly Activities Report and Appendix 4C-BXN.AX
26/10/16	PRICE SENSITIVE	223.13KB	Share
BXN Notice of Annual General Meeting/Proxy Form-BXN.AX
24/10/16		915.76KB	Share
BXN Recruitment for Clinical Trial of Proprietary Probiotic PCC-BXN.AX
17/10/16		135.19KB	Share
BXN Annual Report to shareholders-BXN.AX
29/09/16		825.15KB	Share
BXN Appendix 4G and Corporate Governance Statement-BXN.AX
29/09/16		236.02KB	Share
BXN Becoming a substantial holder-BXN.AX
12/09/16		146.52KB	Share
BXN Ceasing to be a substantial holder-BXN.AX
09/09/16		926.49KB	Share
BXN Management Restructure-BXN.AX
01/09/16		140.75KB	Share
BXN Company Secretary Appointment/Details of Company Address-BXN.AX
01/09/16		131.99KB	Share
BXN Appendix 4E - Preliminary Final Report-BXN.AX
30/08/16	PRICE SENSITIVE	676.8KB	Share
BXN Appendix 4C - June Quarterly-BXN.AX
28/07/16	PRICE SENSITIVE	578.81KB	Share
BXN Bioxyne Commences New Clinical Trial-BXN.AX
23/06/16	PRICE SENSITIVE		Share
BXN Bioxyne Commences New Clinical Trial-BXN.AX
23/06/16	PRICE SENSITIVE	323.48KB	Share
BXN Directors Equity Based Incentives-BXN.AX
15/06/16		398.12KB	Share
BXN Board Exercises Options-BXN.AX
05/05/16		238.83KB	Share
BXN Appendix 3B - Exercise of Directors' Options-BXN.AX
05/05/16		529.67KB	Share
BXN Change of Director's Interest Notice - Patrick Ford-BXN.AX
05/05/16		227.31KB	Share
BXN Change of Director's Interest Notice - Anthony Ho-BXN.AX
05/05/16		225.46KB	Share
BXN Change of Director's Interest Notice - George Cameron-Dow-BXN.AX
05/05/16		227.82KB	Share
BXN Appendix 4C - March quarterly-BXN.AX
26/04/16	PRICE SENSITIVE	578.96KB	Share
BXN Bioxyne Announces 2016 Goals
31/03/16		335.38KB	Share
BXN Bioxyne Investor Presentation
29/03/16		2.12MB	Share
BXN Change of Director's Interest Notice - A Ho
16/03/16		225.28KB	Share
BXN Appendix 4D - Half Yearly Report and Accounts
26/02/16	PRICE SENSITIVE	1.4MB	Share
BXN Initial Director's Interest Notice - Dr Peter French
15/02/16		290.07KB	Share
BXN Appointment of Executive Director Dr Peter French
15/02/16		330.67KB	Share
BXN Tony Ho - Change of Director's Interest Notice
04/02/16		303.66KB	Share
BXN Appendix 4C - December Quarterly
21/01/16	PRICE SENSITIVE	387.19KB	Share
BXN Results of Annual General Meeting
20/11/15		259.72KB	Share
BXN Mariposa Health Inc. Investment Update
11/11/15	PRICE SENSITIVE	330.15KB	Share
BXN Change of Director's Interest Notice - Patrick Ford
02/11/15		470.63KB	Share
BXN Appendix 4C - September Quarterly
29/10/15	PRICE SENSITIVE	486.61KB	Share
BXN 2015 Notice of Annual General Meeting and Proxy Form
20/10/15		734.56KB	Share
BXN Appendix 4G
01/10/15		212.86KB	Share
BXN 2015 Annual Report to Shareholders
30/09/15		1.59MB	Share
BXN Appendix 4E - Preliminary Final Report
31/08/15	PRICE SENSITIVE	701.11KB	Share
BXN 2015 Financial Year Profit Update
17/08/15	PRICE SENSITIVE	222.27KB	Share
BXN Appendix 4C - June Quarterly
30/07/15	PRICE SENSITIVE	619.87KB	Share
BXN Becoming a Substantial Holder - Ondek Pty Ltd
20/05/15		1.01MB	Share
BXN Change of Director's Interest Notice - George Cameron-Dow
20/05/15		265.67KB	Share
BXN Ceasing to be a substantial holder - Fleming
20/05/15		72.57KB	Share
BXN Appendix 4C - March Quarterly
28/04/15	PRICE SENSITIVE	551.29KB	Share
BXN Change of Director's Interest Notice - George Cameron-Dow
16/04/15		265.62KB	Share
BXN Appendix 4D - Half Yearly Report and Accounts
27/02/15	PRICE SENSITIVE	1.56MB	Share
BXN Change of Director's Interest Notice - P Ford
10/02/15		480.18KB	Share
BXN Change of Director's Interest Notice - A Ho
30/01/15		262.07KB	Share
BXN Appendix 4C - December Quarterly
28/01/15	PRICE SENSITIVE	681.79KB	Share
BXN Change of Director's Interest Notice - A Ho
11/12/14		262.83KB	Share
BXN Change of Director's Interest Notice - P Ford
11/12/14		453.3KB	Share
BXN Change of Director's Interest Notice - G Cameron-Dow
11/12/14		458.84KB	Share
BXN Appendix 3B - Issue of Employee Options
11/12/14		978.87KB	Share
BXN Change of Registered Office
28/11/14		238.07KB	Share
BXN Results of 2014 Annual General Meeting
28/11/14		305.74KB	Share
BXN Change of Director's Interest Notice - P Ford
24/11/14		452.8KB	Share
BXN Change of Director's Interest Notice - A Ho
21/11/14		451.1KB	Share
BXN Notice of 2014 Annual General Meeting/Proxy Form
29/10/14		1.5MB	Share
BXN Appendix 4C - September Quarterly
27/10/14	PRICE SENSITIVE	667.26KB	Share
BXN Annual Report to Shareholders
30/09/14		1.61MB	Share
BXN Appointment of Strategic Marketing Consultant
18/09/14		355.39KB	Share
BXN Appendix 4E - Preliminary Final Report
29/08/14	PRICE SENSITIVE	895.86KB	Share
BXN Top 20 securityholders
19/08/14		360.84KB	Share
BXN Appendix 4C - June Quarterly
28/07/14	PRICE SENSITIVE	666.03KB	Share
BXN Initial Director's Interest Notice - George Cameron-Dow
21/07/14		374.54KB	Share
BXN Final Director's Interest Notice - Jeremy Curnock-Cook
21/07/14		336.03KB	Share
BXN Resignation and Appointment of Directors
21/07/14		309.78KB	Share
BXN Change of Director's Interest Notice - Jeremy Curnock-Cook
21/07/14		714.87KB	Share
BXN Ceasing to be substantial holder - Phillip Asset Management
21/07/14		25.35KB	Share
BXN Becoming a substantial holder - Fleming SG Capital SO
21/07/14		126.61KB	Share
BXNOptions Expiry
16/05/14		300.54KB	Share
BXNAppendix 4C - March Quarterly
30/04/14	PRICE SENSITIVE	686.08KB	Share
BXNAppendix 3B - Quotation Following ASX Escrow Release
04/04/14		1.39MB	Share
BXNChange of Director's Interest Notice - P Ford
01/04/14		410.13KB	Share
BXNRelease of Shares from Escrow
18/03/14		311.47KB	Share
BXNHalf Yearly Report and Accounts
28/02/14	PRICE SENSITIVE	1.97MB	Share
BXNChange of Director's Interest Notice - P Ford
25/02/14		719.66KB	Share
BXNCompletion of the Sale of HI-164 Program
25/02/14		256.2KB	Share
BXNChange of Director's Interest Notice - P Ford
19/02/14		720.44KB	Share
BXNChange in substantial holding
14/02/14		512.17KB	Share
BXNAppendix 4C - December Quarterly
31/01/14	PRICE SENSITIVE	672.9KB	Share
BXNAmended Change of Director's Interest Notices
31/01/14		1.33MB	Share
BXNChange of Director's Interest Notice - P Ford
30/01/14		48.4KB	Share
BXNChange of Director's Interest Notice - J C Cook
30/01/14		46.95KB	Share
BXNChange of Director's Interest Notice - A P Ho
30/01/14		48.02KB	Share
BXNAppendix 3B - EGM Approved Share and Option Issues
27/12/13		1.01MB	Share
BXNResults of EGM
23/12/13		435.71KB	Share
BXNExpiry of Unquoted Options
04/12/13		301.97KB	Share
BXNBioxyne Limited CEO Steps Down
02/12/13	PRICE SENSITIVE	181.25KB	Share
BXNSale of HI-164OV Hunter Immunology Pty Ltd
02/12/13	PRICE SENSITIVE	233.45KB	Share
BXNResults of 2013 AGM
29/11/13		418.92KB	Share
BXNNotice of Extraordinary General Meeting/Proxy Form
22/11/13		639.37KB	Share
BXNResponse to ASX query
06/11/13	PRICE SENSITIVE	381.53KB	Share
BXNAppendix 4C - September Quarterly
31/10/13	PRICE SENSITIVE	664.58KB	Share
BXNNotice of Annual General Meeting/Proxy Form
31/10/13		546.76KB	Share
BXN30 June 2013 Full Year Statutory Accounts
23/09/13		1.78MB	Share
BXNAppendix 4E - Preliminary Final Report
30/08/13	PRICE SENSITIVE	1.1MB	Share
BXNResponse to ASX query
06/08/13	PRICE SENSITIVE	378.6KB	Share
BXNAppendix 4C - June Quarterly
31/07/13	PRICE SENSITIVE	650.81KB	Share
BXNCompany Secretary Resignation
06/06/13		315.29KB	Share
BXNTermination of proposed acquisition - Vitality Devices
23/05/13	PRICE SENSITIVE	216.52KB	Share
BXNAppendix 4C - quarterly - 31 March 2013
30/04/13	PRICE SENSITIVE	650.95KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.2¢		Change -0.001(0.96%)		Mkt cap ! $111.8M

Open	High	Low	Value	Volume
5.2¢	5.3¢	5.1¢	$36.15K	701.6K

Buyers (Bids)

No.	Vol.	Price($)
4	822057	5.1¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	130000	2

View Market Depth

No.	Vol.	Price($)
4	822057	0.051
4	132140	0.050
3	239387	0.049
1	100000	0.048
3	213829	0.047

Price($)	Vol.	No.
0.052	130000	2
0.053	691598	3
0.054	266706	3
0.055	468603	3
0.056	324348	3

Last trade - 10.38am 13/08/2025 (20 minute delay)


Last 5.2¢		Change -0.001 ( 1.89 %)
Open	High	Low	Volume
5.2¢	5.2¢	5.1¢	355780
Last updated 10.54am 13/08/2025 ?

BXN (ASX) Chart

BIOXYNE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories